The apolipoprotein E gene, attention, and brain function

Neuropsychology

Volumn 16, Issue 2, 2002, Pages 254-274

  Parasuraman, Raja ^a   Greenwood, Pamela M ^a   Sunderland, Trey ^b  

^a CATHOLIC UNIVERSITY OF AMERICA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BRAIN FUNCTION; DEPTH PERCEPTION; HUMAN; HUMAN TISSUE; MEMORY; PRIORITY JOURNAL; RISK FACTOR; SPATIAL DISCRIMINATION;

EID: 0036209552     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.16.2.254     Document Type: Article

References (228)

1. Normal and abnormal memory: Aging and Alzheimer's disease
2. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: Implications for the cognitive reserve hypothesis
3. Cortical control of saccades and fixation in a man: A PET study
4. Visual search for feature and conjunction targets with an attention deficit
5. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease
6. Temporal aspects of visual search studied by transcranial magnetic stimulation
7. Spatial working memory and spatial selective attention
8. Working memory and vigilance: Evidence from normal aging and Alzheimer's disease
9. Working memory and dementia
10. On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
11. Primary memory and secondary memory deficits in Alzheimer's disease
12. Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: The EVA study
13. Evidence of genetic linkage of Alzheimer's disease to chromosome 10q
14. Alpha-2 macroglobulin is genetically associated with Alzheimer's disease
15. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
16. Episodic memory changes are associated with the ApoE-e4 allele in nondemented older adults
17. Patterns of brain activation in people at risk for Alzheimer's disease
18. Neuropathological staging of Alzheimer-related changes
19. Temporal sequence of Alzheimer's disease-related pathology
20. Is Posner's "beam" the same as Triesman's "glue"?: On the relation between visual orienting and feature integration theory
21. Spatial- and object-based attention deficits in Alzheimer's disease: Relationship to HMPAO-SPECT measures of parietal perfusion
22. Behavioral enhancement of visual responses in monkey cerebral cortex: I. Modulation in posterior parietal cortex related to selective attention
23. Orienting of visual attention in Alzheimer's disease: Its implication in favor of the interhemispheric balance
24. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia
25. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
26. Preclinical memory decline in cognitive normal apolipoprotein E-e4 homozygotes
27. Size of the attentional focus and efficiency of processing
28. Visual selection mediated by location: Selecting successive visual objects
29. The effects of the avetylcholinesterase inhibitor ENA713 and the M1 agonist AF150(S) on apolipoprotein deficient mice
30. Patterns of cognitive decline in presymptomatic Alzheimer's disease
31. Executive dysfunction in Alzheimer's disease
32. Specific hippocampal voltime reductions in individuals at risk for Alzheimer's disease
33. A common network of functional areas for attention and eye movements
34. Voluntary orienting is dissociated from target detection in human posterior parietal cortex
35. A PET study of visuospatial attention
36. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction
37. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
38. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
39. Narrowing the spotlight: A visual attentional disorder in presumed Alzheimer's disease
40. Age differences in recall and recognition
41. Clinical, pathological and neurochemical changes in dementia: A subgroup with pathologically confirmed Alzheimer's disease
42. Early diagnosis of Alzheimer's disease: An introduction
43. Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements
44. Inhibitory processes in covert orienting in patients with Alzheimer's disease
45. Local infusion of scoplamine into intraparietal cortex slows covert orienting in rhesus monkeys
46. Cholinergic markers in elderly patients with early signs of Alzheimer's disease
47. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron emission tomography (FDG/PET)
48. The radiological prediction of Alzheimer's disease: The atrophic hipppocampal formation
49. Selective attention and the organization of visual information
50. Visual attention within and around the field of focal attention: A zoom lens model
51. Allocation of attention in the visual field
52. Linkage of plasma Aβ42 to quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
53. Central cholinergic systems and cognition
54. Assessing the heritability of attentional networks
55. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease
56. Inhibition of return and visuospatial attention in healthy older adults and individuals with dementia of the Alzheimer type
57. Apolipoprotein e4 allele and cognitive decline in elderly men
58. Directed and divided attention in Alzheimer's disease: Impairment in shifting of attention to global and local stimuli
59. Abnormally rapid disengagement of covert attention to global and local stimulus levels may underlie the visuoperceptual impairment in Parkinson's disease
60. Visual attention and perception in patients with Huntington's disease: Comparisons with other subcortical and cortical dementias
61. Where in the brain does visual attention select the forest and the trees?
62. Contribution of age, genes, and environment to the relationship between perceptual speed and cognitive ability
63. Smooth pursuit dysfunction in Alzheimer's disease
64. The misplaced-objects task: A brief test for memory dysfunction in the aged
65. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults
66. Visual attention deficits in Alzheimer's disease: Simple versus conjoined feature search
67. Focal cortical changes shown by positron emission tomography
68. Selective delayed response deficits in Parkinson's and Alzheimer's disease
69. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
70. Genes for cognitive function: Developments on the X
71. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice
72. Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia
73. Functional compensation in Alzheimer's disease
74. Attentional disengagement deficit in nondemented elderly over 75 years of age
75. Attention in aging and Alzheimer's disease: Behavior and neural systems
76. Scale of attentional focus in visual search
77. Controlling the focus of spatial attention in visual search: Effects of advanced aging and Alzheimer's disease
78. Visuospatial attention across the adult life span
79. Genetics and visual attention: Selective deficits in healthy adult carriers of the ε4 allele of the apolipoprotein E gene
80. Age differences and similarities in the effects of cues and prompts
81. Visual attention modulates signal detectability
82. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease
83. Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early Alzheimer's-type dementia
84. The association of apolipoprotein E polymorphism with memory: A population based study
85. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample
86. Apolipoprotein E receptors: Linking brain development and Alzheimer's disease
87. Apolipoprotein E and Alzheimer's disease: A review of recent studies
88. The effect of adaptive air traffic control (ATC) decision aiding on controller mental workload
89. Aletered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique
90. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease
91. Visual attention and eye movements
92. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease
93. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia
94. Apolipoprotein E and cognitive change in an elderly population
95. Alzheimer's disease: Cell pathology isolates the hippocampal formation
96. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease
97. Relationship between oxidative stress and ApoE phenotype in Alzheimer's disease
98. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease
99. Brain perfusion imaging predicts survival in Alzheimer's disease
100. Cortical responses to sustained and divided attention in Alzheimer's disease
101. Overt and covert shifts of visual spatial attention in Alzheimer's disease
102. Nicotinic receptors in the brain: Correlating physiology with function
103. Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia
104. Education and the prevalence of Alzheimer's disease
105. Clinical, pathological and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques
106. Neuroanatomical and neuropathological changes in normal aging and in dementia
107. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy
108. Orienting of visual attention
109. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
110. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease
111. Abeta associated neuropil changes: Correlation with neuronal loss and dementia
112. Shifts in selective visual attention: Towards the underlying neural circuitry
113. Lower cognitive performance of older football players possessing apolipoprotein E epsilon-4
114. Neuroanatomic overlap of working memory and spatial attention networks: A functional MRI comparison within subjects
115. Theory of attentional operations in shape identification
116. Alzheimer disease, attention, and the cholinergic system
117. Acetylcholine affects the spatial distribution of attention: Evidence from Alzheimer's disease
118. Candidate gene for the chromosome I familial Alzheimer's disease locus
119. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation
120. Apolipoprotein E-ε2 and Alzheimer's disease
121. Combined nicotinic and muscarinic blockade in elderly normal volunteers: Cognitive, behavioral, and physiologic responses
122. Electrophysiological approaches to the study of selective attention in the human brain
123. Effects of spatial cuing on luminance detectability: Psychophysical and electrophysiological evidence for early selection
124. Dynamics of the spatial scale of visual attention revealed by brain eventrelated potentials
125. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
126. Neural mechanisms of visual selective attention
127. Neurochemistry of attention
128. An attentional grasp reflex in patients with Alzheimer's disease
129. Asymmetries in the covert orienting of visual spatial attention to spatial and nonspatial cues in Alzheimer's disease
130. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation
131. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease
132. Attention and aging: A functional perspective
133. The role of cortical cholinergic afferent projections in cognition: Impact of new selective immunotoxins
134. Clinical diagnosis of Alzheimer's disease: Report on the NINCDS-ADRDA Work Group
135. A cortical network of directed attention and unilateral neglect
136. ApoE genotype affects when - Not whether - One is predisposed to develop Alzheimer disease
137. Early-life risk factors and the development of Alzheimer's disease
138. A double-blind FDG PET study of the effects of scopolamine in older adults
139. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease
140. Attentional and executive dysfunction
141. Susceptibility locus for Alzheimer's disease on chromosome 10
142. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
143. Forest before trees: The precedence of global features in visual perception
144. Semantic memory in Alzheimer's disease
145. Cognitive dysfunction in Alzheimer's disease
146. Sparing of semantic memory in Alzheimer's disease
147. Divided attention and metabolic brain dysfunction in mild dementia of the Alzheimer's type
148. Functional localization of the system for visuospatial attention using positron emission tomography
149. Attention deficit in Alzheimer's disease is not simulated by an anticholinerergic/antihistaminergic drug and is distinct from deficits in healthy aging
150. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women
151. Memory load and event rate control sensitivity decrements in sustained attention
152. The attentive brain: Issues and prospects
153. Cognitive tests of visual attention in early Alzheimer's disease
154. Attention
155. Selective attention in aging and dementia
156. Selective impairment of spatial attention during visual search in Alzheimer's disease
157. Alzheimer's disease reduces the dynamic range of spatial attention in visual search
158. Visuospatial attention in dementia of the Alzheimer type
159. Attention and brain function in Alzheimer's disease: A review
160. Cognition in Alzheimer's disease: Disorders of attention and semantic knowledge
161. Energetics of attention and Alzheimer's disease
162. Preserved cognitive operations in early Alzheimer's disease
163. Induction of visual extinction by rapid-rate transcranial magnetic stimulation of parietal lobe
164. Attention and executive deficits in Alzheimer disease: A critical review
165. Cholinergic neurotransmission influences covert orientation of visuospatial attention in the rat
166. Apolipoprotein E e4 allele and hippocampal volume in twins with normal cognition
167. Orienting of attention
168. Components of attention
169. Attentional networks
170. The attention system of the human brain
171. Effects of parietal injury on covert orienting of attention
172. Attentional and oculomotor influences on visual field anistropies in visual search
173. Isoform-specific effects of human apoliprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females
174. Apolipoprotein E and cognitive performance
175. Topography of Alzheimer's disease: Involvement of association neocortices and connected regions; pathological, metabolic and cognitive correlations; relation to evolution
176. Commentary: Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease
177. Lower cognitive performance in normal older adult male twins carrying the Apolipoprotein E e4 allele
178. Preclinical evidence of Alzheimer's Disease in persons homozygous for the e4 allele for apolipoprotein E
179. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease
180. Cognitive function and apolipoprotein E in very old adults: Findings from the Nun Study
181. Effects of lesions of temporal-parietal junction on perceptual and attentional processing in humans
182. Covert orienting and attention in macaques: II. Contributions of parietal cortex
183. Alterations of visual search strategy in Alzheimer's disease and aging
184. Clinical and neuroimaging features of familial Alzheimer's disease
185. Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease
186. Further analysis of the cognitive effects of tetrohydoracridine (THA) in Alzheimer's disease: Assessment of attentional and mnemonic function using CANTAB
187. The cognitive neuroscience of sustained attention: Where top-down meets bottom-up
188. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
189. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
190. Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements
191. The role of attention in a spatial memory task in Alzheimer disease patients
192. The effects of preclinical dementia on estimates of normal cognitive functioning in aging
193. Is ApoE-epsilon 4 a risk factor for cognitive impairment in normal aging?
194. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
195. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease
196. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
197. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease
198. Apolipoprotein E genotype influences cognitive "phenotype" in patients with Alzheimer's disease but not in healthy controls
199. Apolipoprotein E: An allele associated with many diseases
200. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study
201. Stroop performance in healthy younger and older adults and in individuals with dementia of the Alzheimer's type
202. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
203. Longitudinal stability of CSF tau levels in Alzheimer patients
204. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus
205. Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitive able elderly volunteers
206. The binding problem
207. A feature integration theory of attention
208. Basal forebrain lesions in monkeys disrupt attention but not learning and memory
209. Neuronal nicotinic receptors: From the gene to the disease
210. A primate model of Alzheimer's disease
211. Childhood mental ability and dementia
212. Nicotinic acetylcholine binding sites in Alzheimer's disease
213. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease
214. Effects of altering brain cholinergic activity on covert orienting of attention: Comparison of monkey and human performance
215. Covert orientation of visual attention in Parkinson's disease: An impairment in the maintenance of attention
216. Comparative effects of ageing and dementia of the Alzheimer type on orientation of visual attention
217. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women
218. Cognitive impairment among elderly adults in Shanghai, China
219. Eye movements reveal the spatiotemporal dynamics of visual search